about
Shiga Toxins as Multi-Functional Proteins: Induction of Host Cellular Stress Responses, Role in Pathogenesis and Therapeutic ApplicationsThe role of complement in the pathogenesis of renal ischemia-reperfusion injury and fibrosisThe European Hematology Association Roadmap for European Hematology Research: a consensus documentHaemolytic uraemic syndrome.Autoantibodies to CD59, CD55, CD46 or CD35 are not associated with atypical haemolytic uraemic syndrome (aHUS).Extra-renal manifestations of complement-mediated thrombotic microangiopathies.ADAMTS-13 in the Diagnosis and Management of Thrombotic Microangiopathies.Podocyte dysfunction in atypical haemolytic uraemic syndrome.Characterization of a New DGKE Intronic Mutation in Genetically Unsolved Cases of Familial Atypical Hemolytic Uremic SyndromeComplement in disease: a defence system turning offensiveComplete remission of thrombotic microangiopathy after treatment with eculizumab in a patient with non-Shiga toxin-associated bacterial enteritis: A case report.Anti-complement-factor H-associated glomerulopathies.Whole-exome sequencing of a patient with severe and complex hemostatic abnormalities reveals a possible contributing frameshift mutation in C3AR1.Thrombotic microangiopathy caused by methionine synthase deficiency: diagnosis and treatment pitfalls.HUS and atypical HUS.Endothelial dysfunction during long-term follow-up in children with STEC hemolytic-uremic syndrome.Fecal diagnostics in combination with serology: best test to establish STEC-HUS.Association among Complement Factor H Autoantibodies, Deletions of CFHR, and the Risk of Atypical Hemolytic Uremic Syndrome.Reincarnation of ancient links between coagulation and complement.Dangerous liaisons: complement, coagulation, and kallikrein/kinin cross-talk act as a linchpin in the events leading to thromboinflammation.Unusual severe case of hemolytic uremic syndrome due to Shiga toxin 2d-producing E. coli O80:H2.Rare Variants in the Complement Factor H-Related Protein 5 Gene Contribute to Genetic Susceptibility to IgA Nephropathy.Shiga Toxins Induce Apoptosis and ER Stress in Human Retinal Pigment Epithelial Cells.Atypical hemolytic uremic syndrome: Korean pediatric series.Atypical hemolytic uremic syndrome and eculizumab therapy in children.Genotypic Features of Clinical and Bovine Escherichia coli O157 Strains Isolated in Countries with Different Associated-Disease Incidences.Differences and similarities between disseminated intravascular coagulation and thrombotic microangiopathyShort- and Long-Term Renal Outcome of Hemolytic-Uremic Syndrome in ChildhoodAn approach to differential diagnosis of antiphospholipid antibody syndrome and related conditions
P2860
Q26752966-CE849784-27E3-4000-92DA-0E95FCC1B9CFQ26853263-2CC810C0-D777-4657-AFF4-EA4E2AB07733Q28830861-348BE6A4-B1FB-468E-BFF2-E963493CA022Q30244707-D1D41E4F-7013-48E3-B142-AC95BB015401Q33417246-D4B1A205-038C-42A7-A3EA-EC13245B1A64Q33417814-5A54AB47-0193-4359-8D08-9A720B4045A1Q33418645-2AF40A5A-8D07-4E48-8E95-29E4F737C975Q33419853-B80A8045-FF46-4E5E-9F3F-2ED218BDAD35Q33421800-52E7E8D2-4BBC-44F3-86BA-202E185D5E2BQ33432423-A9294570-64B9-4579-8E8D-579169012C7DQ33433788-235CDD26-8954-4437-880F-EBE5DBD0C35BQ33434103-3EBEFF80-E864-4C55-A823-EE2A47516D60Q33434795-C65E69B6-1102-4B9B-8549-792A9B03F3BDQ33439434-AF39958A-91C4-4D39-BE66-9AF4054A4398Q33441069-7B4BC055-98CE-4A07-B940-48A010A3A5E2Q36274870-E2D15F56-0070-4A68-85F8-1418D47AE9D3Q37290075-814C0236-6155-43BB-AA2B-11C7FE89D774Q37546464-27149866-368F-405B-A3B3-A9A093E2D614Q38543278-7934B337-5DF3-458A-8451-4D1D46AACE2AQ38991010-90AA8B10-B509-4A50-A7BD-E57D57123B40Q40278428-6FF5D34C-B919-457E-A7C3-6DE298FCA39AQ40974164-5C2A1EB3-0B34-4A27-86C5-01CEE80150E8Q44652100-BA915BD4-ABFD-498B-95DD-BA8327A7C3CAQ54183133-D965707E-4E56-454C-B572-94145CC4B9E0Q54207419-59B65423-1813-4EDD-A865-961F1AF56568Q54226740-DAA3E339-2DB3-4631-B479-A95CCB3AF61CQ57193608-7D74ABFF-72AC-419F-98DE-6115E2F6EC45Q58797348-7DA45988-0F44-48B9-907F-204485C5ACDEQ59075500-F1F143B9-AFB3-437D-A5CB-3D482B959269
P2860
description
wetenschappelijk artikel
@nl
наукова стаття, опублікована в лютому 2014
@uk
name
Hemolytic uremic syndrome
@en
Hemolytic uremic syndrome
@nl
type
label
Hemolytic uremic syndrome
@en
Hemolytic uremic syndrome
@nl
prefLabel
Hemolytic uremic syndrome
@en
Hemolytic uremic syndrome
@nl
P2860
P1476
Hemolytic uremic syndrome
@en
P2093
Caterina Mele
Marina Noris
P2860
P2888
P304
P356
10.1007/S00281-014-0416-X
P577
2014-02-14T00:00:00Z